FDA OKs COVID-19 booster shot for people 65 and older, or at high-risk

2021-09-23 11:28:43Xinhua Editor : Li Yan ECNS App Download
Special: Battle Against Novel Coronavirus

The U.S. Food and Drug Administration (FDA) on Wednesday authorized booster shots of Pfizer's COVID-19 vaccine for people aged 65 and older or at high-risk.

"After considering the totality of the available scientific evidence and the deliberations of our advisory committee of independent, external experts, the FDA amended the EUA (emergency use authorization) for the Pfizer-BioNTech COVID-19 Vaccine to allow for a booster dose in certain populations such as health care workers, teachers and day care staff, grocery workers and those in homeless shelters or prisons, among others," said Acting FDA Commissioner Janet Woodcock.

"This pandemic is dynamic and evolving, with new data about vaccine safety and effectiveness becoming available every day. As we learn more about the safety and effectiveness of COVID-19 vaccines, including the use of a booster dose, we will continue to evaluate the rapidly changing science and keep the public informed," said Woodcock.

The FDA said boosters are authorized for people between the ages of 18 through 64 who are at high risk, as well as those "whose frequent institutional or occupational exposure" to the virus puts them at high risk of serious complications of COVID-19.

The agency said booster doses are to be administered at least six months after completion of the second shot. 


Most popular in 24h

MoreTop news


Back to top About Us | Jobs | Contact Us | Privacy Policy
Copyright ©1999-2021 All rights reserved.
Reproduction in whole or in part without permission is prohibited.
[网上传播视听节目许可证(0106168)] [京ICP证040655号]
[京公网安备 11010202009201号] [京ICP备05004340号-1]